Clinical Trial Update: Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy of 17-alpha-hydroxyprogesterone caproate for preventing preterm delivery has been completed and results are report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• 17-alpha-hydroxyprogesterone caproate (17-alpha-hydroxyprogesterone caproate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Preterm Delivery | Phase 4 | Status: COMPLETED